Through its life cycle from the insect vector to mammalian hosts
In the natural course of infection, the infected insect transmits metacyclic trypomastigotes that invade mammalian cells, escape the endocytic vacuole and transform into rounded amastigote forms. Amastigotes replicate in the cytoplasm, differentiate back into trypomastigotes that are released after cell lysis. An alternative sub-cycle can occur in the mammalian host if amastigotes, originated from premature lysis of infected cells (Behbehani 1973 , Nogueira & Cohn 1976 , Carvalho et al. 1981 , Umezawa et al. 1985 , Ulisses de Carvalho & De Souza 1986 or by extracellular differentiation of trypomastigotes (Pan 1978 , Andrews et al. 1987 , Ley et al. 1988 , Mortara 1991 , invade professional or non-professional phagocytes. Inside these cells the amastigotes can survive and sustain the parasite's life cycle. These amastigote-like infective forms present morphological, immunological, biochemical and ultrastructural similarities to intracellular amastigotes (Villalta & Kierszenbaum, 1982 , Hudson et al. 1984 , Andrews et al. 1987 , Ley et al. 1988 ) and express specific molecular markers of amastigotes (Andrews et al. 1987 , Lima et al. 1988 , Pan & McMahon-Pratt 1989 . We have seen that extracellular amastigotes are able to infect HeLa cells by interacting with microvilli on the dorsal surface of these cells (Mortara 1991) . This association leads to microvillus aggregation that can be followed by microfila-ment clustering observed by phalloidin staining. By contrast, trypomastigotes preferentially enter HeLa cells at the edges showing that the different forms of the parasite interact with specific regions of the cell surface (Mortara 1991) . Differences in invasion mechanisms utilized by extracellular amastigotes and metacyclic trypomastigotes became even more apparent when we tested the requirement for integrity of host cells' cytoskeleton. For that HeLa and Vero cells were treated with drugs that disrupt microfilaments or microtubules. Mammalian cells with altered expression in actinbinding proteins (Actin-Binding Protein, ABP, and gelsolin) were also tested as target cells. Protein kinase inhibitors (staurosporine and genistein) interfered with the invasion processes. The distribution of different host cell components during the invasion by the two parasite forms was consistent with the emerging notion that extracellular amastigotes and metacyclic trypomastigotes utilize mechanisms to invade host cells with highly distinctive features for each Trypanosoma cruzi form and for each host cell. Preliminary data from our studies also suggest that culture-derived trypomastigotes and metacyclic trypomastigotes may form parasito-phorous vacuoles with distinct properties.
MATERIALS AND METHODS
Vero, HeLa, Actin-binding mutants and transfectants, gelsolin transfectants, Coxiella burnetti-chronically infected Vero cells were routinely grown in DME or RPMI-1640 media supplemented with fetal calf serum and antibiotics when necessary. Parasites from different T. cruzi strains were maintained in LIT medium and trypo-mastigotes generated by infecting Vero cells. Amastigotes were obtained from infected cells (intracellular) or after 48 hr incubation of tissue-culture trypomastigotes in LIT medium at 37ºC (extracellular).
RESULTS AND DISCUSSION
We have started our study trying to understand how extracellular amastigotes invade mammalian cells. Earlier work from several groups indicated that this is a common observation and we decided to initiate our studies by comparing the mechanism of cell invasion with that of metacyclic trypomastigotes, the vectorial infective form extensively studied by our colleagues.
It was initially observed that intracellular amastigotes of several strains were poorly infective to non-phagocytic cells and extracellular amastigotes of the highly infective CL strain were much less invasive than G-strain derived parasites. Interestingly, the infectivity to HeLa cells of extracellular amastigotes correlated with the expression of a carbohydrate epitope defined by monoclonal antibody 1D9 (Barros et al. 1997 , Verbisck et al. 1998 (Figure) .
The infectivity of extracellular amastigotes and metacyclic trypomastigotes of the G strain towards different mammalian target cells was then systematically examined. We observed that amastigotes normally displayed a higher capability of invasion on most cells. The effect of drugs that interfere with microfilament (cytochalasin D) or microtubule (nocodazole) assembly on the invasion of the two infective forms was also not only cell (HeLa or Vero) but also infective form dependent (Procópio et al. 1998) .
We also tested cells with modified expression in microfilament-associated components (gelsolin and actin-binding protein, ABP) as target cells and again observed contrasting results with the two infective forms of the parasite. Drugs that interfere with protein phosphorylation (genistein and staurosporine) also displayed contrasting effects (Procópio et al. 1998) .
The recruitment of extracellular matrix components of HeLa and Vero cells, their integrin receptors and cytoskeletal elements was examined under electron and confocal fluorescence microscopy and significant differences were again found in the pattern involving either trypomastigote or extracellular amastigote invasion (Procópio et al. 1998) .
We have also began to examine the formation and escape from the parasitophorous vacuole by the infective forms. We observed that whilst extracellular amastigotes and metacyclic trypomastigotes are found in LAMP-1 positive compartments after 1 hr following infection, extracellular amastigotes appear to escape faster from the vacuole than metecyclics do. Moreover, preliminary results using Vero cells chronically infected with the ryckettsia C. burnetti that induce the formation of large and highly fusogenic cytoplasmic vacuoles (Veras et al. 1994 (Veras et al. , 1995 has disclosed an unforeseen feature of trypomastigote invasion. Indeed, metacyclic trypomastigotes (CL strain) are much more efficiently transferred from the extracellular medium to the C. burnetti vacuole than the corresponding tissue-culture derived trypomastigotes under identical conditions. If this observation is confirmed, it would imply that the composition of the parasitophorous membrane involving the two types of trypomastigotes is distinct.
These studies have thus emphasized the notion that the mechanism involved in the entry of different T. cruzi infective forms depends not only on the host cell but also on the parasite stage.
Expression of epitopes defined by Mab 1D9 and infectivity to HeLa cells of extracellular amastigotes of different Trypanosoma cruzi strains and clones. The expression of the epitopes of the indicated MAbs was examined in amastigotes of different strains and clones (expressed as OD 490 nm, grey bars). Extracellular amastigotes were tested for in vitro invasion of HeLa cells and the intracellular parasites scored in at least 400 cells, determined in at least three independent experiments. Invasion index calculated as in (Procópio et al. 1998) are expressed as open bars. OD 490 nm
